查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363005

透明质酸酶市场规模、份额、趋势分析报告：按类型、用途、地区、细分趋势，2023-2030

Hyaluronidase Market Size, Share & Trends Analysis Report By Type (Animal Derived, Synthetic), By Application (Dermatology, Chemotherapy), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

透明质酸酶市场成长与趋势：

根据Grand View Research, Inc.最新报告，预计2030年全球透明质酸酶市场规模将达到17.346亿美元，2023年至2030年年复合成长率为8.4%。

多年来，微创整容手术的重要性显着增加，并且已经进行了各种人口统计研究来评估世界各地（尤其是已开发国家）整容手术的采用模式。

玻尿酸填充剂是世界各地进行的微创美容手术中最重要的结构要素。微创整容手术的兴起预计将对市场成长产生积极影响，因为执行这些手术时主要首选透明质酸酶。皮肤填充剂在微创脸部美容手术中具有重要用途，导致报告的併发症数量不断增加。

临床医师必须充分了解玻尿酸注射併发症的相关併发症，才能有效治疗。建立适合紧急情况的有效行动方案至关重要，以便在手术或治疗现场可以轻鬆获得所需的药物。这有助于控制透明质酸填充剂注射的负面影响。

透明质酸酶市场报告亮点

  • 2022 年，动物源性透明质酸酶领域占据最大收益占有率，达到 67.0%，预计在整个预测期内将维持这一趋势。
  • 预计合成透明质酸酶领域在预测期内的年复合成长率将达到 9.4%，是最快的。
  • 2022 年，皮肤科细分市场占最大销售份额，约 44.6%。
  • 预计化疗领域在预测期内年复合成长率最快，达 10.5%。
  • 由于新型美容疗法的高普及，北美地区在 2022 年以 38.0% 的最大收益占有率主导市场。此外，该地区的皮肤科医生正在开发新的非手术美容手术和基于透明质酸酶的填充剂，这些在可注射真皮填充剂中受到强烈建议。
  • 由于基于透明质酸酶的疗法有许多开拓的成长机会，预计亚太地区将呈现最快的成长。
  • 强大的本地製造商网路对该地区的收益做出了重大贡献。

目录

第1章调查方法和范围

第2章执行摘要

第3章透明质酸酶市场变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 透明质酸酶市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章透明质酸酶：类型估计与趋势分析

  • 透明质酸酶市场：要点
  • 透明质酸酶市场：2022 年和 2030 年趋势和市场占有率分析
  • 动物源性透明质酸酶
  • 合成透明质酸酶

第5章透明质酸酶：用途估算与趋势分析

  • 透明质酸酶市场：要点
  • 透明质酸酶市场：2022 年和 2030 年趋势和市场占有率分析
  • 皮肤科
  • 化疗
  • 眼科
  • 整形外科
  • 其他的

第6章透明质酸酶市场：区域估计与趋势分析

  • 区域展望
  • 按地区分類的透明质酸酶市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Amphastar Pharmaceuticals, Inc.
    • PrimaPharma, Inc.
    • Halozyme, Inc.
    • Bausch & Lomb Incorporated
    • The Cooper Companies Inc.
    • Sun Pharmaceutical Industries Ltd.
    • STEMCELL Technologies Inc.
    • Shreya Life Sciences Pvt. Ltd.
Product Code: GVR-4-68038-132-0

Hyaluronidase Market Growth & Trends:

The global hyaluronidase market size is expected to reach USD 1,734.6 million by 2030 growing at a CAGR of 8.4% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The significance of minimally invasive cosmetic procedures has increased considerably over the years and various demographic research studies have been conducted to evaluate the adoption pattern of cosmetic treatments across the globe, especially in developed countries.

Hyaluronic acid fillers form the most important component of minimally invasive aesthetic procedures carried out across the globe. Since hyaluronidase is mostly preferred while conducting these procedures, a growing number of minimally invasive aesthetic surgeries are expected to positively impact market growth. Dermal fillers have significant applications in minimally invasive facial aesthetic procedures, which has also led to an increase in the number of reported complications.

Clinicians are required to be entirely aware of the symptoms associated with hyaluronic acid injection complications in order to treat them effectively. It is crucial to establish effective protocols of action suitable for emergencies wherein the desired agents are readily available at the site of surgery or treatment. This aids in controlling the adverse impact of hyaluronic acid filler injections.

Hyaluronidase Market Report Highlights:

  • Animal derived hyaluronidase segment held the largest revenue share of 67.0% in 2022 and are anticipated to maintain this trend throughout the forecast period
  • Synthetic hyaluronidase segment is anticipated to register the fastest CAGR of 9.4% over the forecast period
  • The Dermatology segment held the largest revenue share of approximately 44.6% in 2022
  • The chemotherapy segment is estimated to register the fastest CAGR of 10.5% over the forecast period.
  • North America dominated the market in 2022 with the largest revenue share of 38.0% due to the high penetration of novel cosmetic treatments. In addition, dermatologists in this region are developing new non-surgical cosmetic procedures and hyaluronidase-based injectables which are among the highly recommended injectable dermal fillers
  • Asia Pacific is projected to witness the fastest growth owing to the numerous untapped growth opportunities in hyaluronidase-based treatments
  • A robust network of local manufacturers has significantly contributed to the revenue generated from this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hyaluronidase Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Hyaluronidase Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Hyaluronidase: Type Estimates & Trend Analysis

  • 4.1. Hyaluronidase Market: Key Takeaways
  • 4.2. Hyaluronidase Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Animal-derived hyaluronidase
    • 4.3.1. Animal-derived hyaluronidase market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Synthetic hyaluronidase
    • 4.4.1. Synthetic hyaluronidase market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hyaluronidase: Application Estimates & Trend Analysis

  • 5.1. Hyaluronidase Market: Key Takeaways
  • 5.2. Hyaluronidase Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Dermatology
    • 5.3.1. Dermatology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Chemotherapy
    • 5.4.1. Chemotherapy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Ophthalmology
    • 5.5.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Plastic Surgery
    • 5.6.1. Plastic Surgery market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Hyaluronidase Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Hyaluronidase Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Amphastar Pharmaceuticals, Inc.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. PrimaPharma, Inc.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Halozyme, Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Bausch & Lomb Incorporated
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. The Cooper Companies Inc.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Sun Pharmaceutical Industries Ltd.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. STEMCELL Technologies Inc.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Shreya Life Sciences Pvt. Ltd.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America hyaluronidase market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 7 Canada hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 9 Europe hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 10 Europe hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 11 Europe hyaluronidase market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 14 UK hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 16 France hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 17 France hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 18 Italy hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 20 Spain hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 22 Sweden hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 23 Sweden hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 24 Norway hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 25 Norway hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 26 Denmark hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 27 Denmark hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific hyaluronidase market, by region, 2018 - 2030 (USD Million)
  • Table 31 China hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 32 China hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 33 Japan hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 34 Japan hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 35 India hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 36 India hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 37 Australia hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 38 Australia hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 39 Thailand hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 40 Thailand hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 41 South Korea hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 42 South Korea hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 43 Latin America hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 44 Latin America hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 45 Latin America hyaluronidase market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 47 Brazil hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 48 Mexico hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 49 Mexico hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 50 Argentina hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 51 Argentina hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa hyaluronidase market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 56 South Africa hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 59 UAE hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 60 UAE hyaluronidase market, by application, 2018 - 2030 (USD Million)
  • Table 61 Kuwait hyaluronidase market, by type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait hyaluronidase market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Hyaluronidase: Market outlook
  • Fig. 9 Hyaluronidase: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Hyaluronidase market driver impact
  • Fig. 15 Hyaluronidase market restraint impact
  • Fig. 16 Hyaluronidase market strategic initiatives analysis
  • Fig. 17 Hyaluronidase market: Type movement analysis
  • Fig. 18 Hyaluronidase market: type outlook and key takeaways
  • Fig. 19 Animal derived hyaluronidase market estimates and forecasts, 2018 - 2030
  • Fig. 20 Synthetic hyaluronidase market estimates and forecasts, 2018 - 2030
  • Fig. 21 Hyaluronidase market: Application movement analysis
  • Fig. 22 Hyaluronidase market: Application outlook and key takeaways
  • Fig. 23 Dermatology market estimates and forecasts, 2018 - 2030
  • Fig. 24 Chemotherapy market estimates and forecasts, 2018 - 2030
  • Fig. 25 Ophthalmology market estimates and forecasts, 2018 - 2030
  • Fig. 26 Plastic surgery market estimates and forecasts, 2018 - 2030
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030
  • Fig. 28 Global Hyaluronidase market: Regional movement analysis
  • Fig. 29 Global Hyaluronidase market: Regional outlook and key takeaways
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 33 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 34 UK market estimates and forecasts, 2018 - 2030
  • Fig. 35 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 36 France market estimates and forecasts, 2018 - 2030
  • Fig. 37 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 38 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 39 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 40 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 41 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 42 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 43 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 44 China market estimates and forecasts, 2018 - 2030
  • Fig. 45 India market estimates and forecasts, 2018 - 2030
  • Fig. 46 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 49 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 50 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 51 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 53 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 54 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 55 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030